Related Experiment Video

Updated: Jun 13, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Subtle variations in Pten dose determine cancer susceptibility

Andrea Alimonti1, Arkaitz Carracedo, John G Clohessy

  • 1Cancer Genetics Program, Department of Medicine, Beth Israel Deaconess Cancer Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Nature Genetics
|April 20, 2010
PubMed

Insights

Subtle reductions in tumor suppressor gene (TSG) dosage, like Pten, can promote cancer. This study demonstrates that even with Pten levels above heterozygosity, mammary tissues showed altered biology and gene expression, leading to tumor development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Cancer susceptibility is linked to genetic alterations in tumor suppressor genes (TSGs).
  • Hypotheses suggest subtle TSG expression variations can drive cancer, but in vivo evidence is limited.
  • PTEN (Phosphatase and tensin homolog) is a critical TSG frequently altered in human cancers and inherited cancer syndromes.

Purpose of the Study:

  • To investigate the in vivo impact of subtle reductions in TSG expression on cancer development.
  • To explore the role of PTEN dosage in tumorigenesis, particularly in breast cancer.
  • To present an alternative model for cancer initiation based on reduced TSG dose.

Main Methods:

  • Analysis of Pten hypermorphic mice (Pten(hy/+)) expressing 80% of normal Pten levels.
  • Characterization of tumor spectrum and penetrance in Pten(hy/+) mice, focusing on breast tumors.
  • Examination of Pten levels and gene expression profiles in mammary tissues and tumors.

Main Results:

  • Pten(hy/+) mice developed a range of tumors, with high penetrance of breast tumors.
  • All analyzed breast tumors retained two intact Pten copies and Pten levels above heterozygosity.
  • Subtle Pten downregulation altered mammary tissue biology and expression of proliferation-related genes.

Conclusions:

  • Reduced PTEN dosage, even above heterozygous levels, can predispose to tissue-specific tumorigenesis.
  • This study supports a model where subtle TSG dose reductions contribute to cancer development.
  • Altered gene expression profiles in response to reduced PTEN highlight pathways involved in cancer progression.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...